Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study
Fig 2
Kaplan-Meier cumulative incidence of developing fracture among five groups (P<0.001, log-rank test) (n = 26,642).